
LB42708
CAS No. 226929-39-1
LB42708( LB42708 | LB-42708 | LB 42708 )
Catalog No. M17445 CAS No. 226929-39-1
LB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 52 | Get Quote |
![]() ![]() |
5MG | 79 | Get Quote |
![]() ![]() |
10MG | 133 | Get Quote |
![]() ![]() |
25MG | 263 | Get Quote |
![]() ![]() |
50MG | 392 | Get Quote |
![]() ![]() |
100MG | 550 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLB42708
-
NoteResearch use only, not for human use.
-
Brief DescriptionLB42708 is an orally active farnesyltransferase (FTase) inhibitor (IC50: 0.8/1.2/2.0 nM toward H/N/K-ras).
-
DescriptionLB42708 is a potent, orally active and selective nonpeptidic farnesyltransferase inhibitor (FTase inhibitor). LB42708 inhibited VEGF-induced Ras activation and subsequently suppressed angiogenesis in vitro and in vivo by blocking the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/p38 mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric-oxide synthase pathways in endothelial cells without altering FAK/Src activation.
-
In VitroLB42708 induces cell death despite K-ras prenylation. Growth inhibition by LB42708 is accompanied by G1 and G2/M cell cycle arrests in H-ras and K-ras-transformed RIE cells, respectively. LB42708 induces the upregulation of p21(CIP1/WAF1) and RhoB above the basal level that leads to the cell cycle arrest and to distinct morphological alterations of ras-transformed rat intestinal epithelial (RIE) cells.
-
In Vivo——
-
SynonymsLB42708 | LB-42708 | LB 42708
-
PathwayOthers
-
TargetOther Targets
-
RecptorFarnesyl transferase (FTase)| Farnesyl transferase (FTase)| Farnesyl transferase (FTase)
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number226929-39-1
-
Formula Weight555.46
-
Molecular FormulaC30H27BrN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (180.03 mM)
-
SMILESBrc1ccc(Cn2cncc2Cn2cc(C(=O)N3CCOCC3)c(c2)c2cccc3ccccc23)cc1
-
Chemical Name(1-((1-(4-bromobenzyl)-1H-imidazol-5-yl)methyl)-4-(naphthalen-1-yl)-1H-pyrrol-3-yl)(morpholino)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Na HJ, et al. J Immunol. 2004, 173(2), 1276-1283.
molnova catalog



related products
-
WKYMVM 2TFA(187986-1...
WKYMVM 2TFA is a N-formyl peptide receptor (FPR1) agonist.Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells.Using blood samples withdrawn from 28 AL patients and 31 healthy controls, found that, in the absence of exogenous WKYMVm, WKYMVm receptor and bactericidal activity did not differ between patients and controls.?
-
H-HoArg-OH
H-HoArg-OH a homologue arginine is a strong inhibitor of human bone and liver alkaline phosphatase.
-
Soraprazan
Soraprazan is a reversible, and fast-acting gastric H+/K+ ATPase inhibitor.